Chlorhexidine compared with povidone-iodine as skin preparation before blood culture: A randomized, controlled trial

Annals of Internal Medicine

Volumn 131, Issue 11, 1999, Pages 834-837

  Mimoz, Olivier ^a,b   Karim, Amal ^a,c   Mercat, Alain ^a,c   Cosseron, Marie ^a,c   Falissard, Bruno ^b   Parker, Fabrice ^a,c   Richard, Christian ^a,c   Samii, Kamran ^a,c   Nordmann, Patrice ^a,c  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; POVIDONE IODINE;

ADULT; ARTICLE; BLOOD CULTURE; CLINICAL TRIAL; CONTAMINATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; PHLEBOTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN;

EID: 0033534079     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-131-11-199912070-00006     Document Type: Article

References (20)

1. Strand CL, Wajsbort RR, Sturmann K. Effect of iodophor vs iodine tincture skin preparation on blood culture contamination rate. JAMA. 1993;269:1004-6.
2. Widmer AF. Infection control and prevention strategies in the ICU. Intensive Care Med. 1994;20(Suppl 4):7-11.
3. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339-43.
4. Mimoz O, Pieroni L, Lawrence C, Edouard A, Costa Y, Samii K, et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med. 1996;24:1818-23.
5. Garland JS, Buck RK, Maloney P, Durkin DM, Toth-Lloyd S, Duffy M, et al. Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J. 1995;14:510-6.
6. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233-9.
7. Bates DW, Goldman L, Lee TH. Contaminant blood cultures and resource utilization. The true consequences of false-positive results. JAMA. 1991;265: 365-9.
8. Bates DW, Cook EF, Goldman L, Lee TH. Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med. 1990;113: 495-500.
9. Dunagan WC, Woodward RS, Medoff G, Gray JL 3d, Casabar E, Smith MD, et al. Antimicrobial misuse in patients with positive blood cultures. Am J Med. 1989;87:253-9.
10. Kunisada T, Yamada K, Oda S, Hara O. Investigation on the efficacy of povidone-iodine against antiseptic-resistant species. Dermatology. 1997; 195(Suppl 2):14-8.
11. Aly R, Maibach HI. Effect of antimicrobial soap containing chlorhexidine on the microbial flora of skin. Appl Environ Microbiol. 1976;31:931-5.
12. Stickler DJ, Thomas B, Clayton CL, Chawla JC. Studies of the genetic basis of chlorhexidine resistance. Br J Clin Pract 1983;25:23-30.
13. Lowbury EJ, Lilly HA. The effect of blood on disinfection of surgeons' hands. Br J Surg. 1974;61:19-21.
14. Champagne S, Fussell S, Scheifele D. Evaluation of skin antisepsis prior to blood culture in neonates. Infect Control. 1984;5:489-91.
15. Sakuragi T, Yanagisawa K, Dan K. Bactericidal activity of skin disinfectants on methicillin-resistant Staphylococcus aureus. Anesth Analg. 1995;81:555-8.
16. Sato S, Sakuragi T, Dan K. Human skin flora as a potential source of epidural abscess. Anesthesiology. 1996;85:1276-82.
17. Souvenir D, Anderson DE Jr, Palpant S, Mroch H, Askin S, Anderson J et al. Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol. 1998;36: 1923-6.
18. Baquero F. Gram-positive resistance: challenge for the development of new antibiotics. J Antimicrob Chemother. 1997;39(Suppl A):1-6.
19. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med. 1999;340:493-501.
20. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee (HIPAC). Infect Control Hosp Epidemiol. 1995;16:105-13.